Carl Hogberg

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Interleukin 4 promotes phagocytosis of murine leukemia cells counteracted by CD47 upregulation.

Interleukin 4 promotes phagocytosis of murine leukemia cells counteracted by CD47 upregulation.

Journal: Haematologica
Published: August 25, 2020

CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia.

CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia.

Journal: Cell reports
Published: October 25, 2019

Clonal competition within complex evolutionary hierarchies shapes AML over time.

Clonal competition within complex evolutionary hierarchies shapes AML over time.

Journal: Nature communications
Published: March 27, 2019

Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells.

Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells.

Journal: Haematologica
Published: February 27, 2018

Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.

Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.

Journal: PloS one
Published: May 23, 2017

Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells.

Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells.

Journal: Blood advances
Published: February 22, 2017

IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models.

IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models.

Journal: Blood
Published: November 04, 2015

Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.

Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 12, 2015

Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y₁₂ receptor-mediated platelet aggregation.

Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y₁₂ receptor-mediated platelet aggregation.

Journal: Thrombosis and haemostasis
Published: November 17, 2011
Showing 1-9 of 9

Last Updated: 09/26/2026